170 filings
Page 5 of 9
8-K
5028zqvmt3pg5or3 xr
6 May 14
Sagent Pharmaceuticals Reports First Quarter 2014 Financial Results
12:00am
ARS
bojosd4
2 May 14
Annual report to shareholders
12:00am
UPLOAD
hfolo1jzx0 gwl0yi
12 Feb 14
Letter from SEC
12:00am
8-K
myyir kt98q8b
11 Feb 14
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Results
12:00am
8-K
zk94rlemd4gbjtak
14 Jan 14
Regulation FD Disclosure
12:00am
CORRESP
nbt 16pw08p5al
10 Jan 14
Correspondence with SEC
12:00am
8-K
8rqh pw6i674xbjqub
7 Jan 14
Termination of a Material Definitive Agreement
12:00am
CORRESP
kb3tv
17 Dec 13
Correspondence with SEC
12:00am
UPLOAD
u2xnzs5 55m3
16 Dec 13
Letter from SEC
12:00am
8-K
qfdkcn0xlihecj sv9g
5 Nov 13
Sagent Pharmaceuticals Reports Third Quarter 2013 Financial Results
12:00am
8-K
ew0p7vdiu32dyx
24 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
sd9c1x87lkh8qql86
16 Sep 13
Sagent Pharmaceuticals Announces Upsizing and Pricing of Offering of
12:00am
424B3
3dwhpe
11 Sep 13
Prospectus supplement
12:00am
424B3
68cz t8dt
11 Sep 13
Prospectus supplement
12:00am
424B3
6cvz4nyga9bi80wweh
9 Sep 13
Prospectus supplement
12:00am